ACTRN12624000007538
Recruiting
未知
Prospective Longitudinal Assessment of Treatment options for Young Patients with Upper airway Structural abnormalities (PLATYPUS): a pilot study
Perth Children's Hospital0 sites120 target enrollmentJanuary 9, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Young Children undergoing general anaesthesia
- Sponsor
- Perth Children's Hospital
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients up to 6 months of age/6 months corrected age (if born premature) who have been referred to the Ear, Nose and Throat (ENT) team at PCH for management of suspected laryngomalacia will be recruited.
Exclusion Criteria
- •Children with any syndromic features or neuromuscular conditions
- •Children with known significant cardiac disease
- •Children unable to complete at\-home oximetry
- •Families without a sufficient level of English to be consented.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Prospective longitudinal outcome study assessing the use of REGENOSS for attaining spinal fusion in patients requiring single level Posterior Interbody Fusion (PLIF) in the lumbar spine.NL-OMON47404Finceramica24
Completed
Phase 4
Prospective longitudinal outcome study assessing the use of BonAlive bioactive glass for attaining eradication of osteomyelitis and stimulation of bone healing in patients requiring surgery in osteomyelitic bone defects.NL-OMON46331Medisch Universitair Ziekenhuis Maastricht24
Completed
Not Applicable
Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.Adult T-cell leukemia-lymphomaJPRN-UMIN000009251JSCT30
Recruiting
Not Applicable
Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphomaIndolent B-cell Non-Hodgkin's lymphomaJPRN-UMIN000010175Fukuoka Lymphoma Study Group200
Active, not recruiting
Not Applicable
Prospective observational study for Treatment resistance related gene screening using plasma circulating tumor DNA in the third generation EGFR-TKI Osimertinib therapyJPRN-jRCTs031180051Tamiya Akihiro180